Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 4, 2007, Pages 415-422

  Ito, W ^a   Chiba, T ^a   Kanehiro, A ^b   Kato, H ^a   Yamaguchi, K ^a   Ueki, S ^a   Kayaba, H ^a   Chihara, J ^a  

^a AKITA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Asthma; Chemotaxis; Eosinophil; Hepatocyte growth factor

Indexed keywords

CALCIUM; CD16 ANTIGEN; CYTOKINE; EOTAXIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN D2; SCATTER FACTOR;

ALLERGIC DISEASE; ALLERGIC REACTION; ARTICLE; ATTENUATION; CALCIUM TRANSPORT; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CHEMOTAXIS; EOSINOPHIL; EOSINOPHILIA; HUMAN; HUMAN CELL; INTROSPECTION; MOLECULAR MECHANICS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; TH2 CELL;

CALCIUM; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTAXIS; EOSINOPHILIA; EOSINOPHILS; HEPATOCYTE GROWTH FACTOR; HUMANS; PROSTAGLANDIN D2; RECEPTORS, CHEMOKINE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RECOMBINANT PROTEINS;

EID: 33947146671     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01299.x     Document Type: Article

References (42)

1. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophileotaxin receptor. J Exp Med 1996;183:2349-2354.
2. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996;183:2437-2448.
3. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993;361:315-325.
4. Adachi T, Vita R, Sannohe S, Stafford S, Alam R, Kayaba H et al. The functional role of rho and rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils. J Immunol 2001;167:4609-4615.
5. Boehme SA, Sullivan SK, Crowe PD, Santos M, Conlon PJ, Sriramarao P et al. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol 1999;163:1611-1618.
6. Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 2000;95:1911-1917.
7. Hardy CC, Robinson C, Tattersfield AE, Holgate ST. The bronchoconstrictor-effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984;311:209-213.
8. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193:255-261.
9. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987;224:311-316.
10. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem (Tokyo) 1996;119:591-600.
11. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988;81:414-419.
12. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999;5:226-230.
13. Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998;101:1827-1834.
14. Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Kim S et al. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 2000;102:246-252.
15. Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med 1997;156:1937-1944.
16. Ito W, Kanehiro A, Matsumoto K, Hirano A, Ono K, Maruyama H et al. Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling. Am J Respir Cell Mol Biol 2005;32:268-280.
17. Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 1993;121:145-154.
18. Stoker M. Effect of scatter factor on motility of epithelial cells and fibroblasts. J Cell Physiol 1989;139:565-569.
19. Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ. Association of immunoreactive-hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res 1997;57:433-439.
20. Chihara J, Kurachi D, Yamamoto T, Yamada H, Wada T, Yasukawa A et al. A comparative study of eosinophil isolation by different procedures of CD16-negative depletion. Allergy 1995;50:11-14.
21. Hansel TT, De Vries IJ, Iff T, Rihs S, Wandzilak M, Betz S et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-110.
22. Sawada J, Shimizu S, Tamatani T, Kanegasaki S, Saito H, Tanaka A et al. Stem cell factor has a suppressive activity to IgE-mediated chemotaxis of mast cells. J Immunol 2005;174:3626-3632.
23. Kanegasaki S, Nomura Y, Nitta N, Akiyama S, Tamatani T, Goshoh Y et al. A novel optical assay system for the quantitative measurement of chemotaxis. J Immunol Methods 2003;282:1-11.
24. Sabroe I, Williams TJ, Hebert CA, Collins PD. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol 1997;158:1361-1369.
25. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440- 3450.
26. Sannohe S, Adachi T, Hamada K, Honda K, Yamada Y, Saito N et al. Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis. Eur Respir J 2003;21:925-931.
27. Mizuno S, Matsumoto K, Li MY, Nakamura T. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis. FASEB J 2005;19:580-582.
28. Ueki S, Adachi T, Bourdeaux J, Oyamada H, Yamada Y, Hamada K et al. Expression of PPARgamma ineosinophils and its functional role in survival and chemotaxis. Immunol Lett 2003;86:183-189.
29. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990;111(5 Pt 1):2097-2108.
30. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-641.
31. Weimar IS, de Jong D, Muller EJ, Nakamura T, van Gorp JM, de Gast GC et al. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood 1997;89:990-1000.
32. Jucker M, Gunther A, Gradl G, Fonatsch C, Krueger G, Diehl V et al. The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma. Leuk Res 1994;18:7-16.
33. Borset M, Hjorth-Hansen H, Seidel C, Sundan A, Waage A. Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood 1996;88:3998- 4004.
34. Zeng Q, Chen S, You Z, Yang F, Carey TE, Saims D et al. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NF kappa B. J Biol Chem 2002;277:25203-25208.
35. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB et al. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-324.
36. Li XM, Schofield BH, Wang QF, Kim KH, Huang SK. Induction of pulmonary allergic responses by antigen-specific Th2 cells. J Immunol 1998;160: 1378-1384.
37. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 1962;115:453-466.
38. Kudlacz E, Whitney C, Andresenl C, Conklyn M. Functional effects ofeotaxin are selectively upregulated on IL-5 transgenic mouse eosinophils. Inflammation 2002;26:111-119.
39. Monneret G, Li H, Vasilescu J, Rokach J, Powell WS. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 2002;168:3563-3569.
40. Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact 2006;160:123- 133.
41. Duan HF, Wu CT, Lu Y, Wang H, Liu HJ, Zhang QW et al. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. Exp Cell Res 2004;298:593-601.
42. Tanimura S, Nomura K, Ozaki K, Tsujimoto M, Kondo T, Kohno M. Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility. J Biol Chem 2002;277:28256-28264 (Epub 2002).